4
Changes in Ownership
Intellia Therapeutics, Inc. Filed Acc 0001209191-18-022178
EVP, Chief Financial Officer acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bell Graeme · EVP, Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-03-28 | Exercise or conversion : show line 1 in the form | +8,000 | $13.48 | $107,840 | 21,400 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-03-28 | Exercise or conversion : show line 2 in the form Stock Option (Right to buy) | −8,000 | 202,000 | D |
Loading xslF345X03/doc4.xml…